Tuesday, Dec 10 2024 | Time 11:47 Hrs(IST)
image
Business EconomyPosted at: Nov 8 2024 6:12PM


Granules India receives EIR from US FDA for Unit V Facility

Hyderabad, Nov 8 (UNI) Granules India Limited, a leading pharmaceutical manufacturing company, on Friday announced it has received an Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for its Unit V facility located at Jawaharlal Nehru Pharma City (JNPC), in Anakapalli district of Andhra Pradesh.
The inspection was conducted by the US FDA from April 8 to April 12, 2024, the Pharma company said in a release here.
The US FDA inspection classified the facility as "No Action Indicated" (NAI), indicating compliance with current Good Manufacturing Practices (cGMP) standards and confirming that no further regulatory action is required.
This outcome reflects the facility's high standards in the production of Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for both oncology and non-oncology therapeutic areas.
During the inspection, the FDA conducted a comprehensive Pre-Approval Inspection (PAI) and cGMP audit, which concluded with zero Form 483 observations, underscoring Granules India’s commitment to stringent quality control, regulatory compliance, and operational excellence.
"The successful completion of this US FDA inspection with zero observations and the subsequent receipt of the EIR with NAI status reflects our unwavering commitment to maintaining the highest quality standards in our manufacturing operations," said Dr. Krishna Prasad Chigurupati, Chairman & Managing Director.
Granules India’s Unit V facility plays a pivotal role in the company’s mission to deliver high-quality and accessible pharmaceuticals globally by prioritizing regulatory compliance, operational excellence, and value delivery to stakeholders.
The company remains dedicated to producing top-quality pharmaceutical products that meet global health standards.
UNI KNR CS1811
Please log in to get detailed story.
Tags: #Granules India receives EIR from US FDA for Unit V Facility
More News
USD, Pound, Euro up; Yen down

USD, Pound, Euro up; Yen down

10 Dec 2024 | 10:18 AM

Mumbai, Dec 10 (UNI) Following were the indicative currency rates and travellers' cheques
buying and selling rates.

see more..

Torrent Power raises Rs 3,500 cr via QIP

10 Dec 2024 | 1:40 AM

New Delhi, Dec 9 (UNI) Torrent Power on Monday said that its Qualified Institutions Placement (QIP) saw a very strong demand from investors with the issue being oversubscribed four times against the issue size of Rs 3,500 crore.

see more..

MIT Bengaluru unveils autonomous mobility centre

09 Dec 2024 | 9:53 PM

Bengaluru, Dec 9 (UNI) Manipal Institute of Technology (MIT) Bengaluru, on Monday, launched the Centre of Excellence in Autonomous Mobility, a new initiative designed to foster innovation in the rapidly evolving field of autonomous transportation.

see more..
NABARD, J&K Officials review progress of sanctioned projects of roads and bridge

NABARD, J&K Officials review progress of sanctioned projects of roads and bridge

09 Dec 2024 | 8:15 PM

Jammu, Dec 9 (UNI) The Chief Engineer, PWD, Pir Panjal Zone, Anil Pandohi, and Assistant General Manager, NABARD, Sanjeev Sharma on Monday reviewed the physical progress under 307 rural connectivity projects sanctioned under ongoing tranches of RIDF with an assistance of ₹1130.00 Crore at a meeting in Rajouri, Poonch and Reasi Districts of the Union Territory.

see more..

RSP implements innovative anti-collision system for Slab Yard Cranes

09 Dec 2024 | 8:12 PM

Bhubaneswar, Dec 9 (UNI) The Hot Strip Mill-2 (HSM-2) of Rourkela Steel Plant(RSP) has successfully implemented an innovative anti-collision alarm system for its Electric Overhead Travelling (EOT) cranes in the slab yard.

see more..
image